Form 4: Biomarin Pharmaceutical Executive Sells Shares
Insider Transaction (Form 4)
George Eric Davis, EVP, Chief Legal Officer of Biomarin Pharmaceutical Inc, sold 17,557 shares of common stock on September 2, 2026 for $66.28 per share.
Summary
- Open-market sale: disposed of 17,557 Common Stock at $66.28 ($1,163,748) on September 2, 2026; holds 61,003 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,163,748 of stock on the open market.
Insider Transactions
George Eric Davis — Officer (EVP, Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-02 | Open-market sale | Common Stock | 17,557 | $66 | $1.2M | 61,003 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-02 | Open-market sale (17,557 shares) |
Keywords
insider transaction, Form 4, BMRN, BIOMARIN PHARMACEUTICAL INC, bearish, George Eric Davis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.